|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
1981-1-26
|
|
pubmed:abstractText |
In this pilot study daily low doses of misonidazole (in the range of 1 to 2 g) up to cumulative doses between 7 and 19 g/m2 were used. Serum levels were analysed at different times after administration and according to several dose regimens. We related the cumulative doses to the incidence and severity of the observed peripheral neuropathies. The aim was to find an effective daily low-dose schedule of misonidazole with a clinically acceptable incidence of side effects. Some impressive clinical responses were observed.
|
|
pubmed:language |
ger
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0039-2073
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
156
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
758-64
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:7434385-Adult,
pubmed-meshheading:7434385-Aged,
pubmed-meshheading:7434385-Breast Neoplasms,
pubmed-meshheading:7434385-Female,
pubmed-meshheading:7434385-Genital Neoplasms, Female,
pubmed-meshheading:7434385-Head and Neck Neoplasms,
pubmed-meshheading:7434385-Humans,
pubmed-meshheading:7434385-Male,
pubmed-meshheading:7434385-Middle Aged,
pubmed-meshheading:7434385-Misonidazole,
pubmed-meshheading:7434385-Nervous System,
pubmed-meshheading:7434385-Nitroimidazoles,
pubmed-meshheading:7434385-Time Factors
|
|
pubmed:year |
1980
|
|
pubmed:articleTitle |
[Clinical experience with daily doses of misonidazole (author's transl)].
|
|
pubmed:publicationType |
Journal Article,
English Abstract,
Case Reports
|
